On Valeant's Planner: Congressional Testimony, (Maybe) a New CEO and 10-K
Washington and Wall Street will have their sights on Valeant Pharmaceuticals International Inc. this upcoming week.
Washington and Wall Street will have their sights on Valeant Pharmaceuticals International Inc. this upcoming week.